CoFlo Medical, Inc. filed a Form D with the Securities and Exchange Commission on 2025-11-28.
CoFlo Medical, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 28, 2025. The filing reports $500K sold. Its industry group is Biotechnology. It names Simon Rufer (President, Chief Executive Officer, Secretary), Vishnu Jayaprakash (Treasurer), Matthew Goldman (Director) (SEC Form D, November 28, 2025).
Is this your company?
Sell to companies like CoFlo Medical, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-11-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns CoFlo Medical, Inc.
Free to see. No signup.
More on the people and the money behind CoFlo Medical, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in November 2025, largest first.
Get an email when CoFlo Medical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when CoFlo Medical, Inc. raises, hires or launches. No email unless you switch it on.
Watch CoFlo Medical, Inc. →Get the full cited report on CoFlo Medical, Inc.
What the filing shows about CoFlo Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on CoFlo Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives CoFlo Medical, Inc.'s address as 135 Mississippi Street, San Francisco, CA 94107.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
CoFlo Medical, Inc. is a registered filer with the SEC (CIK 2098562) and has filed since 2025-11-28. 1 filing is on record, the latest on 2025-11-28.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
CoFlo Medical, Inc.'s Form D of 2025-11-28 names Simon Rufer, Vishnu Jayaprakash, Matthew Goldman and 1 more as its officers, directors or promoters.
Its new offerings report $500K sold across 1 offering, as its own filings state.
Trailing twelve months. 764 filings in Biotechnology, totalled by week. The dot is this raise, $500K, on the same scale — one filing against the whole group's total, so it sits low by construction.
On the filing as: Executive Officer, Director.
Simon Rufer is named as President, Chief Executive Officer, Secretary on the Form D that CoFlo Medical, Inc. filed with the SEC on 28 November 2025, one of 4 people that filing names.
On the filing as: Executive Officer.
Vishnu Jayaprakash is named as Treasurer on the Form D that CoFlo Medical, Inc. filed with the SEC on 28 November 2025, one of 4 people that filing names.
Matthew Goldman is named as Director on the Form D that CoFlo Medical, Inc. filed with the SEC on 28 November 2025, one of 4 people that filing names.
Kripa Varanasi is named as Director on the Form D that CoFlo Medical, Inc. filed with the SEC on 28 November 2025, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2025-11-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about CoFlo Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on CoFlo Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CoFlo Medical, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist CoFlo Medical, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind CoFlo Medical, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for CoFlo Medical, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/coflo-medical-inc-form-d-25000001